Navigation Links
FDA Warns About Weight Loss Products
Date:12/22/2008

Agency says more than 2 dozen contain dangerous ingredients not listed on label

MONDAY, Dec. 22 (HealthDay News) -- The U.S. Food and Drug Administration warned consumers Monday to avoid more than two dozen products marketed for weight loss because they contain undeclared ingredients that could pose serious health risks.

The products are sold in some retail stores and on the Internet and some claim to contain only "natural" or "herbal" ingredients. But the undeclared ingredients (not listed on labels) range from an anti-seizure medication to a suspected carcinogen, the FDA said.

The FDA identified the weight loss products as: Fatloss Slimming, Japan Lingzhi 24 Hours Diet, 7 Day Herbal Slim, 999 Fitness Essence, Imelda Perfect Slim, Perfect Slim, ProSlim Plus, Slim Express 360, Superslim, Venom Hyperdrive 3.0, 2 Day Diet, 5x Imelda Perfect Slimming, 8 Factor Diet, Extrim Plus, Lida DaiDaihua, Perfect Slim 5x, Royal Slimming Formula, Slimtech, TripleSlim, 3x Slimming Power, 3 Day Diet, 7 Diet Day/Night Formula, GMP, Miaozi Slim Capsules, Phyto Shape, Slim 3 in 1, Somotrim, and Zhen de Shou.

"These tainted weight loss products pose a great risk to public health because they contain undeclared ingredients and, in some cases, contain prescription drugs in amounts that greatly exceed their maximum recommended dosages," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a news release. "Consumers have no way of knowing that these products contain powerful drugs that could cause serious health consequences. Therefore, FDA is taking this action to protect the health of the American public."

The FDA said an analysis found that the undeclared ingredients in some of these products include sibutramine (a controlled substance), rimonabant (a drug not approved for marketing in the United States), phenytoin (an anti-seizure medication), and phenolphthalein (a solution used in chemical experiments and a suspected cancer-causing agent). Some of the amounts of active ingredients greatly exceed FDA-recommended levels, putting consumers' health at risk, the agency said.

The risks posed by these products can be serious, the FDA said. For instance, sibutramine, which was found in many of the products, can cause high blood pressure, seizures, palpitations, heart attack or stroke. The drug can also interact with other medications that patients may be taking and increase their risk of serious side effects. The safety of sibutramine also hasn't been determined for women who are pregnant or breast-feeding, or in children younger than 16 years of age, the agency said.

Rimonabant was evaluated -- but not approved -- by the FDA for marketing in the United States. The drug, which has been approved in Europe, has been associated with increased risk of depression and suicidal thoughts and has been linked to five deaths and 720 adverse reactions in Europe during the last two years, the agency said in the news release.

Consumers who have used any of these products should stop taking them immediately and consult their health-care professional. And consumers should always seek the guidance of a health-care professional before purchasing weight loss products, the FDA said.

The FDA said it has inspected a number of companies linked to the sale of these products, and is currently seeking to have the products recalled. Citing its own inspections and what it called the companies' "inadequate responses to recall requests," the agency said it may take additional action, including issuing warning letters or seeking criminal charges.

Health care professionals and consumers should report serious side effects or product quality problems to the FDA's MedWatch Adverse Event Reporting program. The e-mail address is www.fda.gov/MedWatch/report.htm. Or call (800) FDA-1088 or Fax (800) FDA-0178.

More information

To learn more, visit the FDA.



--HealthDay Staff



SOURCE: U.S. Food and Drug Administration, news release, Dec. 22, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose
2. Fast Heart Rate Warns of Obesity, Diabetes
3. New Poll Warns Daschle, Obama: Mandatory Health Insurance Big Loser With Public; Voters Want Return on Stem Cell Research
4. Another Study Warns of Risk From Cardiac Surgery Drug
5. Aged care workers to leave industry en masse due to stress, warns University of Melbourne study
6. Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers
7. Ceasefire Broken in Democratic Republic of Congo; International Medical Corps Warns of Looming Humanitarian Catastrophe and Wider Regional Impact
8. FDA Warns of Dangers of Mexican Vanilla
9. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
10. Humanitarian Needs From Georgia Conflict Still Growing, World Vision Warns
11. Lap-Band "Tell-All" Warns of Patients Becoming Lap-Band "Orphans"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... San Mateo, CA (PRWEB) , ... January 19, ... ... now being taken in the 2017 Spring Create Real Impact contest from Impact ... through March 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 ...
(Date:1/19/2017)... ... January 19, 2017 , ... The 21st Century Cures Act’s Impact ... Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          ... Act in order to thrive this year? , The passage of the act means ...
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... board member of the American Osteopathic College of Proctology) announced today the ... removal throughout Southern California ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually learn facts ... doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are common conditions ... this infographic to explain the seven types of hyperhidrosis. This visual creates awareness ...
(Date:1/18/2017)... ... 2017 , ... A Palm Beach doctor plans to run the 2017 London ... provides free surgery to poor children suffering from cleft lip and cleft palate. , ... to support the efforts of the American Heart Association and the Leukemia and Lymphoma ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and PUNE, India , January 18, 2017 ... Market Research, titled, "Breast Imaging Technologies Market by Type: Global ... breast imaging technologies market size was valued at $2,544 million ... 2022, growing at a CAGR of 8.4% from 2016 to ... Europe together accounted for over three-fourths market share ...
(Date:1/18/2017)... Jan. 18, 2017   Spotlight Innovation Inc. ... Therapeutics plans, in the second quarter of 2017, ... roll-on intended to provide relief from chronic pain, ... analgesics. It was developed under a licensing agreement ... products derived from snake venom. Additionally, Caretta Therapeutics ...
(Date:1/18/2017)... DIEGO , Jan. 18, 2017  Dermata ... innovative products to treat a variety of dermatological ... lead compound DMT210, in a Phase 2 acne ... developed to downregulate the proinflammatory cytokines in the ... in acne rosacea. This clinical ...
Breaking Medicine Technology: